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Summary
Papaverine, an inhibitor of CAMP phosphodiesterase, reduced yields of infectious vesicular stomatitis virus in HEp-2 cells approximately lOO-fold if added to cultures at a concentration of 30 PM before and after virus infection. The extent of papaverine-induced suppression of viral growth was dependent on drug dose and treatment regimen. Cells progressively recovered their viral permissive state after removal of drug. The cyclic nucleotide, cGMP, nullified the inhibitory effect of papaverine if added to cells during drug treatment. Pulse labeling experiments with [ 35S]methionine showed that papaverine compromises production of all virus-specific proteins in infected cells without adversely affecting host cell protein synthesis. Treatment of cells with papaverine strongly inhibited the production of viral RNA and both cellular RNA and DNA. It was found that VSV causes an immediate but transient stimulation of DNA synthesis in HEp-2 cells which is prevented by papaverine treatment. This drug also selectively blocked primary transcription of VSV in vivo and to a lesser extent in vitro RNA polymerase activity of the virion-bound transcriptase.
The finding that papaverine has a strong inhibitory effect on viral biosynthesis including early transcription suggests that VSV replication may depend on host factors that regulate intracellular levels of cyclic nucleotides such as CAMP.
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Introduction
The rhabdovirus, vesicular stomatitis virus (VSV), has an unusually broad host range that may reflect, in part, an ability to utilize host regulatory factors which are 58 common to most eurkaryotic cells of higher animals. For example, we have recently shown that inhibitors of cellular prostaglandin biosynthesis prevent VSV replication at the level of viral RNA and protein synthesis (Mukherjee and Simpson, 1984 Simpson, , 1985 . These studies also demonstrated that cells can recover their permissive state for productive viral infections after removal of such inhibitors.
The involvement of cyclic nucleotides and their modulators in the replication of animal viruses has been reported earlier. Exogenous addition of CAMP to cell cultures has been shown to inhibit replication of measles virus (Robbins and Rapp, 1980) . We have recently demonstrated that CAMP can partially reverse the inhibition of VSV replication by indomethacin, a drug which targets various enzyme systems including phosphodiesterase (Mukherjee and Simpson, 1984) . Miller and Carrigan (1982) showed that treatment of neural cells with papaverine. a potent agonist of phosphodiesterase which elevates intracellular CAMP levels, caused a marked but reversible suppression of measles virus growth. Others have found that RNA but not protein synthesis of measles virus can be inhibited by papaverine in neural and non-neural cells (Yoshikawa and Yamanouchi, 1984) . In this communication, it is shown that papaverine prevents both viral RNA and protein synthesis in HEp-2 cells infected with VSV and acts at an early stage of the viral growth cycle.
Virus stocks and cell cultures
The Indiana strain of VSV was grown in cultures of BHK-21 cells for preparation of working stocks (Mukherjee and Simpson, 1984) . Cultures of BHK-21 or HEp-2 cells used in this study were maintained in reinforced MEM (RMEM) supplemented with 10% newborn calf serum (NCS). Infectivity titrations were performed by plaque assay in BHK-21 monolayer cultures as described earlier (Simpson et al., 1979) .
Virus used for primary transcription assays was labeled in its RNA by growth for 36 h in BHK-21 cells with f3H]uridine (specific activity 27.9 Ci/mmol) at 20 pCi/ml and purified by established methods (Bean and Simpson, 1973) .
Assays for viral transcr~~tase activity
The method of Baltimore et al. (1970) For determining primary transcription in vivo, the method of Bean and Simpson (1973) was used with only minor changes and HEp-2 cell monolayers (2 x lo6 cells) were infected with purified 3H-labeled VSV at an input of approximately 5 X 10' cpm (3 X lo6 pfu) per 60 mm Petri dish culture.
Electrophoresis of viral proteins and RNA species
For determination of viral protein synthesis, HEp-2 cells infected with VSV were pulse-labeled with [35S]methionine under different regimens of drug treatment as described in the figure legends. Washed cells, lysed in Laemmli buffer (0.0625 M Tris-HCl, pH 6.8/2% SDS/lo% glycerol), were sonicated for 5 min at 4°C and combined with P-mercaptoethanol and 0.025% bromphenol blue before boiling for 5 min. The dissociated proteins were analyzed by standard discontinuous SDS-PAGE in 10% acrylamide resolving gels (Laemmli, 1970) . The 35S-labeled proteins were detected by autoradiography using Kodak XAR-5 X-ray film exposed with a Cronex lightning-plus intensifying screen for 7-10 days at -80°C. For analysis of viral RNAs, infected HEp-2 cells were pulse-labeled with inorganic [ 3'P]phosphate in phosphate-free RMEM at different times during infection and according to the drug regimens described under Results. Total RNA was extracted from washed monolayers solubilized with STE buffer containing 0.5% SDS. After the lysate was aspirated three times through a 22 gauge needle, the RNA was extracted with STE-saturated phenol and precipitated with 95% ethanol at -20°C (Bean and Simpson, 1973) . RNA preparations dissolved in STE buffer with 8 M urea and 20% glycerol were stored at -20°C until analyzed in 1% agarose acid-urea slab gels by the method of Lynch et al. (1979) . For autoradiography, gels fixed in 50% methanol were exposed to Kodak XAR-5 film with a Cronex lightning-plus intensifying screen at -80°C for 7 days. 
Chemicals

Results
Inhibition of virus yields by papaverine
Preliminary experiments were carried out to establish conditions for maximum inhibition of VSV growth by papaverine in HEp-2 cells. Although papaverine was recently shown to inhibit measles virus replication by more than 99% in neural cell cultures treated at a dose level of 7 FM for 6 days (Miller and Carrigan, 1982) we found that HEp-2 cells required exposure to 30 PM papaverine (before and after infection) to obtain a 98% reduction of virus yields (Table 1) . Use of lower doses or omitting drug after infection was less effective in reducing virus yields. Prolonged drug treatment of HEp-2 cells for more than 2 days produced cytotoxic effects. In all subsequent experiments, HEp-2 cells were treated with drug at a concentration of 30 PM and for periods not exceeding 48 h.
The reversibility of the drug effect was investigated by pretreating cells with papaverine, infecting with virus, and further incubating cells for 24 h before removal HEp-2 cell monolayers were incubated with or without papaverine at the concentrations indicated in RMEM (2% NCS) at 37°C for 24 h before infection with VSV (m.o.i. = 10). The infected cultures were washed after virus adsorption (0 time) and fresh RMEM (lacking serum) with or without papaverine was added. After further incubation at 37'C for 24 h, the cultures were frozen/thawed three times and the clarified lysates were tested for virus content by plaque assay in BHK-21 cells. of drug. Under these conditions, there was a rapid and progressive recovery of the viral permissive state with increasing virus yields seen as a function of time after drug removal ( Table 2 ). The kinetics of virus production during the cell recovery period was similar to that of a group of untreated cultures infected at the same time (24 h p.i.) that papaverine was removed from test cultures, indicating that no viral shown). We also tested the effect of known modulators of cyclic nucleotide metabolism for their ability to counteract the viral inhibitory effect of papaverine. The most significant effect was obtained when cells were exposed to cGMP during treatment with drug (Table 3) . Cyclic GMP totally negated the papaverine block of viral replication if it was present during the entire drug treatment period. Inhibition of measles virus growth in vitro by papaverine is similarly antagonized by exogenous addition of cGMP (Miller and Carrigan, 1982) . Although papaverine is known to affect intracellular levels of Ca2+ ions which in turn can regulate phosphodiesterase activity (Carpendo et al., 1975) , we found that altering the calcium concentration of the culture medium had no apparent effect on inhibition of VSV by this drug (data not shown).
Effect of papaverine on synthesis of viral proteins
To determine the effect of drug on viral protein synthesis, papaverine-treated cells were pulse-labeled with [ 3sS]methionine during infection and total radiolabeled proteins were analyzed in SDS-PAGE gels as illustrated in Fig. 1 . The production of viral proteins was totally blocked in cells infected immediately after drug treatment (Fig. 1, lane 5) even though cellular protein synthesis was not apparently reduced (cf. Fig. 1, lane 4) . Under the conditions employed in these experiments, papaverine reduced yields of infectious virus to 1% of infected control cultures (data not shown). Calcium had no sparing effect on the inhibition of viral protein synthesis by this drug (Fig. 1, lane 6) .
Nucleic acid synthesis in papaverine-treated
cells Our inability to detect VSV proteins in drug-treated cells suggested that either the shows polypeptide components of: 35S-labeled purified VSV particles (Lane 1); mock-treated infected cells (Lane 2); mock-treated infected cells incubated with 0.1 mM CaCl, (Lane 3); papaverine treated mock-infected cells (Lane 4); papaverine treated infected cells without (Lane 5) or with (Lane 6) CaCl,; mock-treated uninfected cells (Lane 7). production or processing of viral mRNAs might be impaired. When papaverinetreated HEp-2 cells were analyzed for RNA species produced during the early stages of infection, none of the expected VSV mRNAs or genome-length 42s RNA were detected (Fig. 2) . Synthesis of cellular ribosomal RNA was also prevented by this drug (Fig. 2, lane 4) .
The effect of papaverine on host DNA synthesis was also examined. Fig. 3 illustrates that ['Hlthymidine uptake in drug-treated cells was totally blocked whether or not they were infected. An interesting aside of these experiments was the finding that immediately after infection with VSV, there was an appreciable stimulation of [3H]thymidine incorporation by comparison with uninfected cells (Fig. 3) . Although the true significance of this phenomenon is unknown, it appears to be related to virus uptake since it was multiplicity dependent and did not occur when Fig. 2 . Gel electrophoresis of RNA species synthesized in HEp-2 ceils treated with papaverine and infected with VSV. Cells pretreated with papaverine (30 PM) for 24 h at 37°C were infected with VSV (10 pfu/cell), incubated with fresh medium containing drug, and labeled with 32P (25 pCi/ml) from 2 to 4 h p.i. Total RNA was extracted and analyzed in acid-urea agarose gels (Materials and Methods). RNA species from: untreated, virus infected cells (Lane 1); infected cells treated with papaverine (Lane 2); mock-treated uninfected cells (Lane 3); uninfected cells treated with papaverine (Lane 4). Arrows indicate the position of 28s and 18s ribosomal RNA, respectively. infected cells were incubated in the cold (data not shown). Collectively. the foregoing experiments established that papaverine blocks host nucleic acid synthesis but not protein synthesis under conditions where no VSV-coded polypeptides or RNA species are produced.
Drug effect on viral transcription
In the absence of viral mRNA synthesis, it was of interest to determine whether papaverine directly affects viral transcription.
We tested for primary transcription in vivo in drug-treated cells by measuring the association of radiolabeled input viral genomic RNA with RNase resistant complexes during the first 2 h of infection (see Materials and Methods). Fig. 4 shows that primary transcription of VSV in ceils w 0 10 Incuba~nTime ( his. )
After Wrus Adsorption
Time of platen ( Min. 1 Fig. 3 . Effect of papaverine on ( 3H]thymidine uptake in HEp-2 cells. Sub#nfluent (ca. 80%) monolayers of HEp-2 cells in 60 mm plates (3 x 10" cells) were treated for 24 h at 37°C with RMEM (2% NCS) containing or lacking 30 PM papaverine. After treatment, the cultures were washed with BSS and either mock-infected (GBSS) or infected with VSV at an input multiplicity of 10 pfu/ceIl. Virus was adsorbed at room temperature for 30 min (0 time) and fresh medium with 30 pM papaverine was added to those cultures pretreated with drug while all others received RMEM without supplements. Separate cultures from each of the experimental groups were pulse-labeled with 1 pCi/mI of [3H]thymidine for 60 min at the time intervals indicated during a 10 h incubation at 37'C. Isotope incorporation was stopped by chilling cultures on ice and acid-insoluble radioactivity was measured (Evans and Simpson, 1980) .
[ 3H]Thymidine uptake is shown as a function of time of pulse-labeling following virus adsorption for drug-treated infected cells (A). drug-treated uninfected cells (A). mock-treated infected cells (0) and mock-treated uninfected cells (0). Fig. 4 . Effect of papaverine on primary transcription of vesicular stomatitis virus in monolayer cultures of HEp-2 cells. Cultures were exposed to RMEM (2% NCS) with or without 30 pM papaverine for 24 h at 37°C. The drug treated cultures were temperature equilibrated at 4°C and inoculated with gradient-purified VSV radiolabeled in its RNA with 'H. The virus input was approximately 10 pfu per ceil or 4 x IO5 cpm. Cells were washed with cold BSS after virus adsorption and incubated at 37°C with pre-warmed (37OC) serum-free medium containing or lacking papaverine (30 PM). Individual cultures were extracted for total RNA at different time intervals and the percentage of ribonuclease resistant radioactivity after annealing was determined (Materials and Methods). Percent RNase-resistant 3H counts as a function of time of incubation for untreated infected cultures (0) and cultures treated before and after infection with drug (0). treated with papaverine before and after infection was largely prevented during the early stages of infection.
To determine whether the impairment of primary transcription seen in these experiments might involve a direct action of drug on viral transcriptive complexes, we tested the activity of the virion transcriptase in in vitro reaction mixtures containing different concentrations of papaverine. As shown in Table 4 , transcriptase activity was incompletely inhibited in reaction mixtures with drug concentrations of 30 PM or higher. Considering that drug levels greater than 30 PM are toxic for the HEp-2 cells used in this study, this partial inhibition of in vitro viral transcriptase activity obtained suggests that the stronger block of VSV transcription induced in vivo may not necessarily reflect a direct effect of papaverine on viral transcriptive complexes under the conditions used. 
Discussion
The use of papaverine in this study as a reversible inhibitor of viral replication further implicates the participation of endogenous host factors in biosynthetic activities of vesicular stomatitis virus during infection of permissive cells. Pharmacologically, papaverine (6,7-dimethoxy-l-veratryl-isoquinoline)
is an alkaloid derivative of Papaver poppies which acts as a smooth muscle relaxant by inhibiting phosphodiesterase, causing an increase in intracellular levels of 3',5'-monophosphate (cyclic AMP) (Triner et al., 1970; Carpendo et al., 1975) . Recent studies on the possible role of cyclic nucleotides as modulators of acute and persistent infections with measles virus have established that elevation of CAMP levels either by exogenous addition of this nucleotide (Robbins and Rapp, 1980) or by treatment of cells with papaverine (Miller and Carrigan, 1982; Yoshikawa and Yamanouchi, 1984) renders cells reversibly nonpermissive for measles virus replication. Yoshikawa and Yamanouchi (1984) reported that papaverine blocks measles virus in vitro at the level of viral RNA synthesis although their ability to detect relatively low levels of measles P protein in neural and non-neural cells treated with this drug would indicate that inhibition of viral transcription in this system was not absolute. Other workers have shown that papaverine can selectively inhibit production of intracellular matrix (M) protein in measles infected neural cells without negatively affecting synthesis of other viral structural proteins detected by immunofluorescent staining (Miller and Carrigan, 1982) . it would thus appear that host cell differences influence the extent to which papaverine interferes with virus-specific macromolecular synthesis observed in these systems. assistance rendered throughout this work. This investigation was supported by funds from Research Grant AI-17262 from the National Institutes of Health, U.S. Public Health Service, and the Charles and Johanna Busch Foundation of Rutgers University.
